The 2024 Implementation report, unveiled at an event co-hosted with the South African Department of Health, and South African Medical Research Council (SAMRC) in Cape Town, highlights that while there have been bright spots at a national level, the world remains insufficiently prepared for 100 day response to a future pandemic. The report is accompanied by the 2nd iteration of the 100DM scorecard which shows that critical gaps remain, particularly in the development and deployment of diagnostics and therapeutics for diseases with pandemic potential. As the world continues to grapple with evolving threats like the resurgence of Mpox, Marburg and Ebola, and the spread of H5N1 as first human fatalities recorded, the report underscores the urgency of building a robust and equitable R&D ecosystem.
What’s inside the Report:
- Progress made towards the 100 Days Mission in 2024
- Challenges, risks, and opportunities on the horizon for medical countermeasure development
- Priority action areas for 2025
- 100 Days Mission Scorecard 2.0 assessing readiness, funding, and R&D pipelines for the expanded WHO priority pathogens with high pandemic potential
- Mpox case study: an analysis of the ongoing mpox response through a 100 Days Mission lens